Literature DB >> 20472623

Anesthetics and the developing brain.

Francine S Yudkowitz1.   

Abstract

In the past decade, concern has been raised about the safety of anesthetic agents on the developing brain. Animal studies have shown an increase in apoptosis in the developing brain when exposed to N-methyl-D-asparate receptor blockers and/or gamma-aminobutyric acid receptor agonists that is related to the dose and duration of anesthetic agents. Whether these studies can be extrapolated to humans is being investigated. The Food and Drug Administration in 2007 convened an advisory committee to look at this issue. They found that the animal data available were inadequate to extrapolate to humans and determined that human studies were necessary. Human studies are underway but the challenge they face is how to delineate the effects of anesthesia from those of the underlying medical condition and surgery itself. At this time, we must continue to make decisions based on the known risks and benefits of anesthetics and apply it on an individual basis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472623     DOI: 10.1177/1089253210362791

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


  3 in total

1.  Aberrantly expressed long noncoding RNAs are involved in sevoflurane-induced developing hippocampal neuronal apoptosis: a microarray related study.

Authors:  Xiaohui Chen; Xue Zhou; Dihan Lu; Xiaoyu Yang; Zhibin Zhou; Xi Chen; Yanqing Chen; Wen He; Xia Feng
Journal:  Metab Brain Dis       Date:  2016-05-27       Impact factor: 3.584

2.  Peritoneal drainage in pneumoperitoneum in extremely low birth weight infants.

Authors:  Ilse Broekaert; Titus Keller; Daisy Schulten; Christoph Hünseler; Angela Kribs; Martin Dübbers
Journal:  Eur J Pediatr       Date:  2018-03-26       Impact factor: 3.183

3.  MicroRNA-34c is regulated by p53 and is involved in sevoflurane-induced apoptosis in the developing rat brain potentially via the mitochondrial pathway.

Authors:  Xue Zhou; Dongfeng Xian; Jiehua Xia; Ying Tang; Wenda Li; Xiaohui Chen; Zhibin Zhou; Dihan Lu; Xia Feng
Journal:  Mol Med Rep       Date:  2017-03-01       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.